Literature DB >> 6085365

Efficacy of nitrendipine as baseline antihypertensive therapy.

H Rüddel, R Schmieder, W Langewitz, J Neus, O Wagner, A W von Eiff.   

Abstract

To determine whether calcium antagonists might be used alternatively to beta-blockers in antihypertensive therapy, we investigated if monotherapy with oxprenolol (160-320 mg/day) and nitrendipine (20-40 mg/day) were equally effective on clinical casual blood pressure (BP), ambulatory BP monitoring (Remler), and BP during mental challenge (video game). In a prospective randomized long-term study, 60 white male civil servants (mean +/- SD = 43 +/- 6 years) with mild essential hypertension only were treated for at least 4 months. Average BP before therapy was 149 +/- 11/97 +/- 11 mm Hg. The antihypertensive effect was not different between the two groups (19/14 versus 21/12 mm Hg). Both groups did not differ in BP at rest, in BP during mental challenge (141 +/- 7/109 +/- 5 versus 146 +/- 9/112 +/- 8 mm Hg, NS), and average ambulatory BP monitoring at work (122 +/- 12/81 +/- 17 versus 132 +/- 14/79 +/- 17 mm Hg, NS), which was identical with the clinical casual BP. Thus, nitrendipine can effectively be used in long-term baseline antihypertensive monotherapy.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6085365

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  9 in total

1.  Inter- and intra-subject variability of nitrendipine and the effects of food.

Authors:  J Lobo; D B Jack; M J Kendall
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

Review 2.  'Second generation' dihydropyridine calcium antagonists. Greater vascular selectivity and some unique applications.

Authors:  D D Freedman; D D Waters
Journal:  Drugs       Date:  1987-11       Impact factor: 9.546

3.  Comparison of casual, ambulatory and self-measured blood pressure in a study of nitrendipine vs bisoprolol.

Authors:  T Mengden; B Bättig; M Schubert; T Jeck; B Weisser; C Buddeberg; W Vetter
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 4.  Nitrendipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of hypertension.

Authors:  K L Goa; E M Sorkin
Journal:  Drugs       Date:  1987-02       Impact factor: 9.546

5.  Antihypertensive efficacy and effects of nitrendipine on cardiac and renal hemodynamics in mild to moderate hypertensive patients: randomized controlled trial versus hydrochlorothiazide.

Authors:  R Scaglione; A Indovina; G Parrinello; R Lipari; L G Mulè; A Ganguzza; G Capuana; C G Stampino; G Licata
Journal:  Cardiovasc Drugs Ther       Date:  1992-04       Impact factor: 3.727

6.  Addition of chlorthalidone to slow-release nifedipine in the treatment of arterial hypertension: a controlled study versus placebo.

Authors:  L A Ferrara; T Marotta; F Pasanisi; P Mastranzo; M Mancini
Journal:  Cardiovasc Drugs Ther       Date:  1988-03       Impact factor: 3.727

7.  Antihypertensive effects of nitrendipine and cilazapril alone, and in combination in hypertensive patients with chronic renal failure.

Authors:  H J Kloke; F T Huysmans; J F Wetzels; H E Sluiter; C H Kleinbloesem; R A Koene
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

8.  A double-blind randomized cross-over study of the efficacy and tolerability of nifedipine and nitrendipine in the treatment of mild to moderate hypertension.

Authors:  A M Heagerty; J D Swales
Journal:  Br J Clin Pharmacol       Date:  1989-04       Impact factor: 4.335

9.  Time course for blood pressure lowering of beta-blockers with partial agonist activity.

Authors:  Xiao-Yin Zhang; Sam Soufi; Colin Dormuth; Vijaya M Musini
Journal:  Cochrane Database Syst Rev       Date:  2020-09-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.